The first-quarter numbers for Emergent BioSolutions (NYSE:EBS) didn’t look too great. In fact, they were arguably ugly.
{iframe}https://www.fool.com/investing/2018/05/08/emergent-biosolutions-moves-things-around.aspx{/iframe}
About BioHealth Innovation
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
Connect
© 2025 BioHealth Innovation.